Capecitabine and oxaliplatin in combination as first or second-line therapy for metastatic breast cancer: A Wisconsin Oncology Network trial

door Njiaju, U.O., Tevaarwerk, A.J., Kim, K., Chang, J.E., Hansen, R.M., Champeny, T.L., Traynor, A.M., Meadows, S., Van Ummersen, L., Powers, K., Stewart, J.A.
Gepubliceerd in 2012